Crispr Therapeutics shares owned by Integral Health Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Integral Health Asset Management
from 13F filings
Historical chart of Integral Health Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Integral Health Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $15M | 220k | 68.16 |
| 2023-09-30 | $13M | 275k | 45.39 |
| 2023-06-30 | $5.6M | 100k | 56.14 |
| 2023-03-31 | $4.5M | 100k | 45.23 |
| 2022-09-30 | $14M | 220k | 65.35 |
| 2022-06-30 | $4.9M | 80k | 60.77 |
| 2022-03-31 | $7.5M | 120k | 62.77 |
More positions owned by Integral Health Asset Management
View all positions for Integral Health Asset Management